Dexilant Solutab

Active Ingredient(s): Dexlansoprazole
FDA Approved: * January 26, 2016
Pharm Company: * TAKEDA DEVELOPMENT CTR AMERICAS INC
Category: Gastrointestinal

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Dexilant Solutab Overview

Dexlansoprazole (trade names Kapidex, Dexilant) is a proton pump inhibitor (PPI) that is marketed by Takeda Pharmaceuticals for the treatment of erosive esophagitis and gastro-oesophageal reflux disease. It is similar in effectiveness to other PPIs.[2] Contents 1 Medical use 2 Adverse effects 3 Mechanism of action 4 Chemistry 5 Pharmacokinetics 6 History 7 References Medical use Dexlansoprazole is used to heal and maintain healing of erosive esophagitis and to treat...

Read more Dexilant Solutab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dexlansoprazole

Recent Dexilant Solutab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Dexlansoprazole

Capsule, Delayed Release: 30mg, 60mg, 90mg
Capsule, Extended Release: 60mg
Tablet, Delayed Release, Orally Disintegrating: 30mg
Tablet, Orally Disintegrating, Delayed Release: 30mg

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Dexilant Solutab: (1 result)

Sorted by National Drug Code

64764-177 Dexilant Solutab 30 mg Oral Tablet, Orally Disintegrating, Delayed Release by Takeda Pharmaceuticals America, Inc.

Dexilant Solutab